CANDICE DEVOL: Open Payments
NPI 1972808970 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 139 payments from 11 companies in 2025. Trend: 2023 $1,535 · 2024 $1,890 · 2025 $2,137
Food & beverage: $2,037Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $997 |
| Amgen Inc. | 44 | $492 |
| Janssen Biotech, Inc. | 8 | $203 |
| UCB, Inc. | 6 | $188 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| GENZYME CORPORATION | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| PFIZER INC. | 1 | $24 |
Products named: RINVOQ, EVENITY, TREMFYA, Bimzelx, OTEZLA, SKYRIZI, KRYSTEXXA, BENLYSTA.
Industry payments across OH — which companies pay providers there.
